ketendoКлиническая и экспериментальная тиреоидологияClinical and experimental thyroidology1995-54722310-3787Endocrinology Research Centre10.14341/ket20117427-31ketendo-4502Research ArticleСтатьиArticlesThyroid dysfunction and hematopoietic systemThyroid dysfunction and hematopoietic systemPetuninaN A

доктор мед. наук, профессор, зав. кафедрой эндокринологии ФППОВ Первого МГМУ им. И.М. Сеченова

NAPetunina@mail.ruMartirosianN S

канд. мед. наук, доцент кафедры эндокринологии

-TruhinaL V

клинический ординатор кафедры эндокринологии

-20111512201174ТОМ 7, №4 (2011)2731Copyright © Petunina N.A., Martirosian N.S., Truhina L.V., 20112011Petunina N.A., Martirosian N.S., Truhina L.V.Petunina N.A., Martirosian N.S., Truhina L.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.cet-endojournals.ru/jour/article/view/4502

В настоящем обзоре проведен анализ современных данных литературы о влиянии гормонов щитовидной железы (ЩЖ) на систему кроветворения, периферические клетки крови, свертывающую и другие системы крови. Часто эти изменения носят приспособительный характер и зависят от активности метаболических процессов. Тем не менее точный механизм действия гормонов ЩЖ на системы крови до сих пор полностью не изучен. При компенсации функциональной активности ЩЖ картина крови обычно полностью восстанавливается и редко требуются дополнительные вмешательства.

ReferencesBraverman L.E., Utiger R.D. The thyroid: a Fundamental and clinical text. 9th ed. Philadelphia: Lippicott Williams & Wilkins 2005. 595–598, 803–806.Braverman L.E., Utiger R.D. The thyroid: a Fundamental and clinical text. 9th ed. Philadelphia: Lippicott Williams & Wilkins 2005. 595–598, 803–806.Calhan T., Senateє E., Cebeci E. et al. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism. Endocrine 2010; 38 (2): 199–205.Calhan T., Senateє E., Cebeci E. et al. A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism. Endocrine 2010; 38 (2): 199–205.Chadarevian R., Bruckert E., Leenhardt L. et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J. Clin. Endocrinol. Metab. 2001; 86 (2): 732–737.Chadarevian R., Bruckert E., Leenhardt L. et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J. Clin. Endocrinol. Metab. 2001; 86 (2): 732–737.Chute J.P., Tyan C.P., Sladek G. et al. Exacerbation of warfarininduced anticoagulation by hyperthyroidism.Endocr Pract. 1997; 3: 77.Chute J.P., Tyan C.P., Sladek G. et al. Exacerbation of warfarininduced anticoagulation by hyperthyroidism.Endocr Pract. 1997; 3: 77.Das K.C., Mukherjee M., Sarkar T.K. et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J. Clin. Endocrinol. Metab. 1975; 40 (2): 211–220.Das K.C., Mukherjee M., Sarkar T.K. et al. Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J. Clin. Endocrinol. Metab. 1975; 40 (2): 211–220.Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine 2009; 36 (1): 110–118.Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine 2009; 36 (1): 110–118.Federici A.B. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Semin. Thromb. Hemost. 2011; 37 (1): 35–40.Federici A.B. Acquired von Willebrand syndrome associated with hypothyroidism: a mild bleeding disorder to be further investigated. Semin. Thromb. Hemost. 2011; 37 (1): 35–40.Fein H.G., Rivlin R.S. Anemia in thyroid diseases. Med. Clin. N. Am. 1975; 59 (5): 1133–1145.Fein H.G., Rivlin R.S. Anemia in thyroid diseases. Med. Clin. N. Am. 1975; 59 (5): 1133–1145.Ford H.C., Carter J.M. The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad. Med. J. 1988; 64 (756): 735–742.Ford H.C., Carter J.M. The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis. Postgrad. Med. J. 1988; 64 (756): 735–742.Golde D.W., Bersch N., Chopra I.J., Cline M.J. Thyroid hormones stimulate erythropoiesis in vitro. Br. J. Haematol. 1977; 37 (2): 173–177.Golde D.W., Bersch N., Chopra I.J., Cline M.J. Thyroid hormones stimulate erythropoiesis in vitro. Br. J. Haematol. 1977; 37 (2): 173–177.Horton L., Coburn R.J., England J.M., Himsworth R.L. The haematology of hypothyroidism. Quart. J. Med. 1976; 45 (177): 101–123.Horton L., Coburn R.J., England J.M., Himsworth R.L. The haematology of hypothyroidism. Quart. J. Med. 1976; 45 (177): 101–123.Kellett H.A., Sawers J.S.A., Boulton F.E. et al. Problems of antico- agulation with warfarin in hyperthyroidism. Quart. J. Med. 1986; 58: 43.Kellett H.A., Sawers J.S.A., Boulton F.E. et al. Problems of antico- agulation with warfarin in hyperthyroidism. Quart. J. Med. 1986; 58: 43.Marongiu F., Conti M., Murtas M.L. et al. Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb. Res. 1991; 64: 745.Marongiu F., Conti M., Murtas M.L. et al. Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb. Res. 1991; 64: 745.Michiels J.J., Budde U., van der Planken M. et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best. Pract. Res. Clin. Haematol. 2001; 14 (2): 401–436.Michiels J.J., Budde U., van der Planken M. et al. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best. Pract. Res. Clin. Haematol. 2001; 14 (2): 401–436.Michiels J.J., Schroyens W., Berneman Z., van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin. Appl. Thromb. Hemost. 2001; 7 (2): 113–115.Michiels J.J., Schroyens W., Berneman Z., van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin. Appl. Thromb. Hemost. 2001; 7 (2): 113–115.Ohashi H., Itoh M. Effects of thyroid hormones on the lymphocyte phenotypes in rats: changes in lymphocyte subsets related to thyroid function. Endocr. Regul. 1994; 28 (3): 117–123.Ohashi H., Itoh M. Effects of thyroid hormones on the lymphocyte phenotypes in rats: changes in lymphocyte subsets related to thyroid function. Endocr. Regul. 1994; 28 (3): 117–123.Olukman O., Sahin U., Kavakli T., Kavakli K. Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine. J. Pediatr. Endocrinol. Metab. 2010; 23 (9): 967–974.Olukman O., Sahin U., Kavakli T., Kavakli K. Investigation of acquired von Willebrand Syndrome in children with hypothyroidism: reversal after treatment with thyroxine. J. Pediatr. Endocrinol. Metab. 2010; 23 (9): 967–974.Omar S., Hadj Taeib S., Kanoun F. et al. Erythrocyte abnormalities in thyroid dysfunction. Tunis Med. 2010; 88 (11): 783–788.Omar S., Hadj Taeib S., Kanoun F. et al. Erythrocyte abnormalities in thyroid dysfunction. Tunis Med. 2010; 88 (11): 783–788.Sievert R., Goldstein M.L., Surks M.I. Graves’ disease and autoimmune factor VIII deficiency. Thyroid 1996; 6: 245.Sievert R., Goldstein M.L., Surks M.I. Graves’ disease and autoimmune factor VIII deficiency. Thyroid 1996; 6: 245.Yango J., Alexopoulou O., Eeckhoudt S. et al. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy. Eur. J. Endocrinol. 2011; 164 (4): 599–603.Yango J., Alexopoulou O., Eeckhoudt S. et al. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy. Eur. J. Endocrinol. 2011; 164 (4): 599–603.Yoshida K. Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months. Rinsho Byori. 2007; 55 (6): 560–565.Yoshida K. Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months. Rinsho Byori. 2007; 55 (6): 560–565.Zeigler Z.R., Hasiba U., Lewis J.H. et al. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am. J. Hematol. 1986; 23: 391.Zeigler Z.R., Hasiba U., Lewis J.H. et al. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am. J. Hematol. 1986; 23: 391.

The authors declare that there are no conflicts of interest present.